These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28361856)

  • 21. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
    Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
    J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CpG island methylation of TMS1/ASC and CASP8 genes in cervical cancer.
    Kordi Tamandani DM; Sobti RC; Shekari M; Huria A
    Eur J Med Res; 2009; 14(2):71-5. PubMed ID: 19258216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Promoter methylation and expression of death-associated protein kinase gene in acute leukemia].
    Zhao WH; Meng FY; Lai YR; Peng ZG; Ma J
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Mar; 37(3):407-410. PubMed ID: 28377362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.
    Narayan G; Freddy AJ; Xie D; Liyanage H; Clark L; Kisselev S; Un Kang J; Nandula SV; McGuinn C; Subramaniyam S; Alobeid B; Satwani P; Savage D; Bhagat G; Murty VV
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1043-53. PubMed ID: 21960365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylation mediated silencing of TMS1/ASC gene in prostate cancer.
    Das PM; Ramachandran K; Vanwert J; Ferdinand L; Gopisetty G; Reis IM; Singal R
    Mol Cancer; 2006 Jul; 5():28. PubMed ID: 16848908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting.
    Schafer E; Irizarry R; Negi S; McIntyre E; Small D; Figueroa ME; Melnick A; Brown P
    Blood; 2010 Jun; 115(23):4798-809. PubMed ID: 20215641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer.
    Virmani A; Rathi A; Sugio K; Sathyanarayana UG; Toyooka S; Kischel FC; Tonk V; Padar A; Takahashi T; Roth JA; Euhus DM; Minna JD; Gazdar AF
    Int J Cancer; 2003 Aug; 106(2):198-204. PubMed ID: 12800194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Alteration of methylation status of death-associated protein kinase (dapk) gene promoter in patients with acute myeloid leukemia].
    Qian J; Yao DM; Lin J; Chen Q; Li Y; Ji RB; Yang J; Qian Z; Xiao GF; Wang YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1390-4. PubMed ID: 21176336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation-induced silencing of ASC/TMS1, a pro-apoptotic gene, is a late-stage event in colorectal cancer.
    Riojas MA; Guo M; Glöckner SC; Machida EO; Baylin SB; Ahuja N
    Cancer Biol Ther; 2007 Nov; 6(11):1710-6. PubMed ID: 17986858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypermethylation of CpG islands in the promoter region of the p15INK4B gene in childhood acute leukaemia.
    Tsellou E; Troungos C; Moschovi M; Athanasiadou-Piperopoulou F; Polychronopoulou S; Kosmidis H; Kalmanti M; Hatzakis A; Dessypris N; Kalofoutis A; Petridou E
    Eur J Cancer; 2005 Mar; 41(4):584-9. PubMed ID: 15737564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypermethylation of CpG island in the promoter region of CALCA in acute lymphoblastic leukemia with central nervous system (CNS) infiltration correlates with poorer prognosis.
    Paixão VA; Vidal DO; Caballero OL; Vettore AL; Tone LG; Ribeiro KB; Lopes LF
    Leuk Res; 2006 Jul; 30(7):891-4. PubMed ID: 16712930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Possible Role for WNT5A Hypermethylation in Pediatric Acute Lymphoblastic Leukemia.
    Hatırnaz Ng Ö; Fırtına S; Can İ; Karakaş Z; Ağaoğlu L; Doğru Ö; Celkan T; Akçay A; Yıldırmak Y; Timur Ç; Özbek U; Sayitoğlu M
    Turk J Haematol; 2015 Jun; 32(2):127-35. PubMed ID: 26316480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypermethylation of p15 gene associated with an inferior poor long-term outcome in childhood acute lymphoblastic leukemia.
    Mai H; Liu X; Chen Y; Li C; Cao L; Chen X; Chen S; Liu G; Wen F
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):497-504. PubMed ID: 26501552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
    Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of DNA hypermethylation in the pathogenesis and prognosis of acute lymphoblastic leukemia.
    Roman-Gomez J; Castillejo JA; Jimenez A; Barrios M; Heiniger A; Torres A
    Leuk Lymphoma; 2003 Nov; 44(11):1855-64. PubMed ID: 14738136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylation mediated silencing of TMS1 in breast cancer and its potential contribution to docetaxel cytotoxicity.
    Gordian E; Ramachandran K; Singal R
    Anticancer Res; 2009 Aug; 29(8):3207-10. PubMed ID: 19661336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ADAMTSL5 and CDH11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia.
    Abdullah M; Choo CW; Alias H; Abdul Rahman EJ; Mohd Ibrahim H; Jamal R; Hussin NH
    Hematology; 2017 Aug; 22(7):386-391. PubMed ID: 28292214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WNT5A, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia.
    Roman-Gomez J; Jimenez-Velasco A; Cordeu L; Vilas-Zornoza A; San Jose-Eneriz E; Garate L; Castillejo JA; Martin V; Prosper F; Heiniger A; Torres A; Agirre X
    Eur J Cancer; 2007 Dec; 43(18):2736-46. PubMed ID: 18032022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.